U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 6, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000781837.1

Allele description [Variation Report for NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg)]

NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg)
HGVS:
  • NC_000003.12:g.38603789C>T
  • NG_008934.1:g.50884G>A
  • NM_000335.5:c.1813G>AMANE SELECT
  • NM_001099404.2:c.1813G>A
  • NM_001099405.2:c.1813G>A
  • NM_001160160.2:c.1813G>A
  • NM_001160161.2:c.1813G>A
  • NM_001354701.2:c.1813G>A
  • NM_198056.3:c.1813G>A
  • NP_000326.2:p.Gly605Arg
  • NP_001092874.1:p.Gly605Arg
  • NP_001092875.1:p.Gly605Arg
  • NP_001153632.1:p.Gly605Arg
  • NP_001153633.1:p.Gly605Arg
  • NP_001341630.1:p.Gly605Arg
  • NP_932173.1:p.Gly605Arg
  • NP_932173.1:p.Gly605Arg
  • LRG_289t1:c.1813G>A
  • LRG_289:g.50884G>A
  • LRG_289p1:p.Gly605Arg
  • NC_000003.11:g.38645280C>T
  • NM_198056.2:c.1813G>A
Protein change:
G605R
Links:
dbSNP: rs1553704001
NCBI 1000 Genomes Browser:
rs1553704001
Molecular consequence:
  • NM_000335.5:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000920187Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 6, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000920187.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The c.1813G>A (p.Gly605Arg) in SCN5A gene is a missense variant involves a mildly conserved nucleotide and 4/4 in silico tools predict damaging outcome, however no functional studies supporting these predictions were published at the time of evaluation. The variant is located within the cytoplasmic domain of voltage-gated Na+ ion channel. The c.1813G>A is absent from the control population datasets of ExAC and gnomAD (111634 and 223734 chrs tested, respectively). To our knowledge, the variant has not been reported in affected individuals via published reports or cited by reputable databases/clinical laboratories. Taken together, the variant was classified as VUS, until new information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024